CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1986; 36:302-309
doi: 10.3322/canjclin.36.5.302
© 1986 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGuire, W. L.
Right arrow Articles by Clark, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGuire, W. L.
Right arrow Articles by Clark, G. M.

CA: A Cancer Journal for Clinicians, Vol 36, 302-309, Copyright © 1986 by American Cancer Society

Role of Progesterone Receptors In Breast Cancer

William L. McGuire M.D.1 and Gary M. Clark Ph.D.2

1 Professor of Medicine and Chief of Oncology at the University of Texas Health Science Center in San Antonio, Texas.
2 Professor of Medicine in the Department of Medicine/Oncology of the University of Texas Health Science Center in San Antonio, Texas.

PRs appear to be an important factor in the prognosis and management of breast cancer. The survival of patients whose tumors lose PRs is significantly shorter than that of those retaining PRs. Frequent reassessment of PRs is therefore recommended to ensure optimal treatment planning for patients who are initially PR positive.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by American Cancer Society.